相关实验视频
Updated: Jul 12, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
恐慌恐惧症和恐慌发作由原发性阿尔多斯特隆症复杂化,通过eplerenone治疗得到改善:一个案例报告
Reoto Kijima1, Hirofumi Tesen2, Ryohei Igata2
1Department of Psychiatry, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, 8078555, Kitakyushu, Fukuoka, Japan. rkijima@med.uoeh-u.ac.jp.
BMC psychiatry
|October 27, 2023
概括
原发性阿尔多斯顿主义 (PA) 可能会导致精神症状,如现在恐惧症和恐慌发作. 使用矿物质皮质类受体对抗剂eplerenone的治疗有效地改善了PA患者的这些症状.
科学领域:
- 内分泌学 在内分泌学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 原发性阿尔多斯子症 (PA) 是一种上腺疾病,导致过多的阿尔多斯子分泌,导致高血压.
- 肺炎与各种症状有关,但与特定精神疾病的关联较少被探索.
研究的目的:
- 报告一例与 agoraphobia 和恐慌发作一起出现的原发性 aldosteronism 的病例.
- 调查eplerenone在管理与PA相关的精神症状中的有效性.
主要方法:
- 一个40岁的女性被诊断出患有PA,并经历了 Agora 恐惧症和恐慌发作的案例研究.
- 使用eplerenone的药理干预,这是一个矿物质皮质类受体对抗剂.
主要成果:
- 患者的精神症状,包括 agoraphobia 和恐慌发作,在治疗eplerenone后显著改善.
- 这一案例表明PA与这些精神病症状之间存在潜在的联系.
结论:
- 这是第一份报告详细介绍了与 Agora 恐惧症和恐慌发作相关的 PA 与药物治疗有反应.
- 应考虑对PA的评估,在患者呈现 agorahobia 和恐慌发作.
- 埃普莱伦是一种潜在的治疗选择,用于管理PA患者的精神症状.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Adrenal Gland Disorders
1.6K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.6K
Antihypertensive Drugs: Direct Renin Inhibitors
650
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
650
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
674
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
674
Antihypertensive Drugs: Potassium-Sparing Diuretics
595
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
595
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K

